Cme (CME) Common Equity (2009 - 2026)

Cme (CME) has reported Common Equity for 18 consecutive years, with $26.5 billion the latest figure, recorded in Q2 2026.

• Quarterly Common Equity fell 4.39% year-over-year to $26.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $26.5 billion (down 4.39% YoY) and the FY2025 annual result came in at $28.7 billion, up 8.46% from the prior year.
• Common Equity held at $26.5 billion in Q2 2026 per CME's latest filing, from $26.6 billion in the prior quarter.
• Over the last five years, Common Equity for CME reached as high as $28.7 billion in Q4 2025 and fell as low as $26.5 billion in Q4 2024.
• A 5-year average of $27.5 billion and a median of $27.7 billion in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2025 — Common Equity rose 8.46% — and 2026, when it fell 4.39%.
• Year by year, Common Equity stood at $26.9 billion in 2022, then slipped by 0.52% to $26.7 billion in 2023, then dropped by 0.94% to $26.5 billion in 2024, then advanced by 8.46% to $28.7 billion in 2025, then decreased by 7.69% to $26.5 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $26.5 billion, $26.6 billion, and $28.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.